Phyllis Hoelsworth, CNMT, is a Clinical Account Executive with SOFIE and a board-certified nuclear medicine technologist with over 30 years of experience in the nuclear medicine industry.

In this session, Dr. Westendorf will detail the incidence, prevalence and survival rates for patients with neuroendocrine tumors (NETs), and more.

In this session, Trevor will discuss the scope of molecular imaging pharmaceuticals in development & their potential role in fulfilling unmet needs in medical care management.

In this session, Dr. Tapp will review the preliminary, interim results from the recently closed CMS Coverage with Evidence Development study, and more.

We're at SNMMI Mid- Winter- Orlando, FL, from January 25-27 2018. Please visit us at Booth #3.